Intra-Cellular Therapies
(NASDAQ) ITCI
Intra-Cellular Therapies Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$680.64M
Net Income (TTM)
$74.68M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ITCI News
ITCI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Intra-Cellular Therapies
Industry
Pharmaceuticals
Sector
Health CareEmployees
860
CEO
Sharon L. Mates, PhD
Headquarters
New York City, NY 10016, US
ITCI Financials
Key Financial Metrics (TTM)
Gross Margin
90%
Operating Margin
-18%
Net Income Margin
-12%
Return on Equity
-4%
Return on Capital
-6%
Return on Assets
-3%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$623.89M
Operating Income
$116.72M
EBITDA
$116.72M
Operating Cash Flow
$73.18M
Capital Expenditure
$322.00K
Free Cash Flow
$73.50M
Cash & ST Invst.
$1.00B
Total Debt
$16.98M
Intra-Cellular Therapies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$199.22M
+51.5%
Gross Profit
$178.82M
+48.0%
Gross Margin
89.76%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
860
N/A
Net Income
$16.89M
+40.9%
EBITDA
$29.09M
+14.3%
Quarterly Fundamentals
Net Cash
$984.09M
+104.6%
Accounts Receivable
$166.50M
+46.0%
Inventory
$26.28M
+125.7%
Long Term Debt
$12.75M
-4.3%
Short Term Debt
$4.23M
+17.2%
Return on Assets
-3.16%
N/A
Return on Invested Capital
-5.86%
N/A
Free Cash Flow
$12.65M
-513.5%
Operating Cash Flow
$13.08M
-534.5%